Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
KL-6
Description:
A circulating glycoprotein biomarker, also known as Krebs von den Lungen-6, used to assess interstitial lung disease and lung injury.
Primary topic:
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42%)
Related topics:
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42%),
Systemic Sclerosis and Related Diseases (7%)
OpenAlex ID:
keywords/kl-6
Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases
2002
·
Hiroshi Ohnishi
, Akihito Yokoyama
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
438
Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases
2012
·
Nobuhisa Ishikawa
, Noboru Hattori
, et al.
·
Respiratory Investigation
·
425
PDF
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis
2010
·
T. Gono
, Y. Kawaguchi
, et al.
·
Rheumatology
·
339
Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosis
2006
·
Akihito YOKOYAMA
, Keiichi KONDO
, et al.
·
Respirology
·
315
KL-6, a Mucin-like Glycoprotein, in Bronchoalveolar Lavage Fluid from Patients with Interstitial Lung Disease
1993
·
Nobuoki Kohno
, Yukikazu Awaya
, et al.
·
American Review of Respiratory Disease
·
296
Detection of Soluble Tumor-associated Antigens in Sera and Effusions Using Novel Monoclonal Antibodies, KL-3 and KL-6, against Lung Adenocarcinoma
1988
·
Nobuoki Kohno, M.D
, Mitoshi Akiyama, M.D
, et al.
·
Japanese Journal of Clinical Oncology
·
285
Serum Indicators for the Diagnosis of Pneumocystis Pneumonia
2007
·
Sadatomo Tasaka
, Naoki Hasegawa
, et al.
·
CHEST Journal
·
284
Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease
2014
·
Tiffany A. Winstone
, Deborah Assayag
, et al.
·
CHEST Journal
·
273
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
2019
·
Dinesh Khanna
, Donald P. Tashkin
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
245
KL-6: A Serum Marker for Interstitial Pneumonia
1995
·
Jun Kobayashi
, Satoshi Kitamura
·
CHEST Journal
·
235
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
2021
·
Wanlong Wu
, Li Guo
, et al.
·
Clinical Reviews in Allergy & Immunology
·
230
Circulating KL-6 Predicts the Outcome of Rapidly Progressive Idiopathic Pulmonary Fibrosis
1998
·
AKIHITO YOKOYAMA
, NOBUOKI KOHNO
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
217
Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis
2014
·
Shinichiro Ohshimo
, Nobuhisa Ishikawa
, et al.
·
Respiratory Medicine
·
207
PDF
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis
2010
·
Harold R. Collard
, Carolyn S. Calfee
, et al.
·
American Journal of Physiology-Lung Cellular and Molecular Physiology
·
205
Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
2019
·
Jeong Seok Lee
, Eun Young Lee
, et al.
·
Arthritis Research & Therapy
·
198
PDF
Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma
2009
·
FAYE N. HANT
, ANNA LUDWICKA-BRADLEY
, et al.
·
The Journal of Rheumatology
·
190
PDF
Staging of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis
2013
·
Tomoo Kishaba
, Hitoshi Tamaki
, et al.
·
Lung
·
189
Plasma Biomarkers for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis*
2013
·
Matty L. Terpstra
, Jurjan Aman
, et al.
·
Critical Care Medicine
·
188
Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome
2004
·
Akitoshi Ishizaka
, Tomoyuki Matsuda
, et al.
·
American Journal of Physiology-Lung Cellular and Molecular Physiology
·
188
KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts
1997
·
Yutaka Hirasawa
, Nobuoki Kohno
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
187
Increased levels of KL‐6 and subsequent mortality in patients with interstitial lung diseases
2006
·
H. SATOH
, K. KURISHIMA
, et al.
·
Journal of Internal Medicine
·
178
PDF
Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment
2012
·
Tsuneyo Mimori
, Ran Nakashima
, et al.
·
Current Rheumatology Reports
·
171
PDF
Fibrosis biomarkers in workers exposed to MWCNTs
2016
·
Liliya M. Fatkhutdinova
, Timur O. Khaliullin
, et al.
·
Toxicology and Applied Pharmacology
·
166
Gastroesophageal Reflux Incites Interstitial Lung Disease in Systemic Sclerosis: Clinical, Radiologic, Histopathologic, and Treatment Evidence
2010
·
Romy B. Christmann
, Athol U. Wells
, et al.
·
Seminars in Arthritis and Rheumatism
·
162
Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease
2019
·
Muriel Elhai
, Anna Maria Hoffmann‐Vold
, et al.
·
Arthritis & Rheumatology
·
161
Show more works
View as search
Works count:
2,279
Citation count:
31,890
Year
Topic
Type